217 related articles for article (PubMed ID: 29444872)
1. FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.
Ettinger RA; Liberman JA; Gunasekera D; Puranik K; James EA; Thompson AR; Pratt KP
Blood Adv; 2018 Feb; 2(4):309-322. PubMed ID: 29444872
[TBL] [Abstract][Full Text] [Related]
2. Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.
Lin JC; Ettinger RA; Schuman JT; Zhang AH; Wamiq-Adhami M; Nguyen PC; Nakaya-Fletcher SM; Puranik K; Thompson AR; Pratt KP
PLoS One; 2015; 10(1):e0116577. PubMed ID: 25615825
[TBL] [Abstract][Full Text] [Related]
3. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
[TBL] [Abstract][Full Text] [Related]
4. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.
James EA; Kwok WW; Ettinger RA; Thompson AR; Pratt KP
J Thromb Haemost; 2007 Dec; 5(12):2399-407. PubMed ID: 18034765
[TBL] [Abstract][Full Text] [Related]
5. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
Jones TD; Phillips WJ; Smith BJ; Bamford CA; Nayee PD; Baglin TP; Gaston JS; Baker MP
J Thromb Haemost; 2005 May; 3(5):991-1000. PubMed ID: 15869596
[TBL] [Abstract][Full Text] [Related]
6. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
[TBL] [Abstract][Full Text] [Related]
7. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4
Gunasekera D; Vir P; Karim AF; Ragni MV; Pratt KP
Front Immunol; 2023; 14():1128641. PubMed ID: 36936969
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.
Ettinger RA; James EA; Kwok WW; Thompson AR; Pratt KP
Haemophilia; 2010 May; 16(102):44-55. PubMed ID: 20536985
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.
James EA; van Haren SD; Ettinger RA; Fijnvandraat K; Liberman JA; Kwok WW; Voorberg J; Pratt KP
J Thromb Haemost; 2011 Apr; 9(4):689-99. PubMed ID: 21251204
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
[TBL] [Abstract][Full Text] [Related]
12. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Wang W; Merchlinsky M; Inman J; Golding B
Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
[TBL] [Abstract][Full Text] [Related]
14. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
15. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
[TBL] [Abstract][Full Text] [Related]
16. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.
Jankowski W; Park Y; McGill J; Maraskovsky E; Hofmann M; Diego VP; Luu BW; Howard TE; Kellerman R; Key NS; Sauna ZE
Blood Adv; 2019 May; 3(9):1429-1440. PubMed ID: 31053570
[TBL] [Abstract][Full Text] [Related]
17. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
Hu GL; Okita DK; Conti-Fine BM
J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach.
Winterling K; Martin WD; De Groot AS; Daufenbach J; Kistner S; Schüttrumpf J
J Thromb Haemost; 2021 Sep; 19(9):2161-2170. PubMed ID: 34060724
[TBL] [Abstract][Full Text] [Related]
19. B-cell and T-cell epitopes in anti-factor VIII immune responses.
Pratt KP; Thompson AR
Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
[TBL] [Abstract][Full Text] [Related]
20. Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo.
Moise L; Song C; Martin WD; Tassone R; De Groot AS; Scott DW
Clin Immunol; 2012 Mar; 142(3):320-31. PubMed ID: 22222093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
